Mersana Therapeutics Inc (MRSN) — Free Cash Flow Generation Index

Latest as of September 2022: 0.99x

Mersana Therapeutics Inc (MRSN) has a Free Cash Flow Generation Index of 0.99x as of September 2022. Free cash flow of $54.17 Million represents 1% of operating cash flow ($54.60 Million). See Mersana Therapeutics Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.99x

Free Cash Flow / Operating CF

Free Cash Flow

$54.17 Million

USD

Operating Cash Flow

$54.60 Million

USD

Capital Expenditures

$426.00K

USD

Mersana Therapeutics Inc Free Cash Flow Generation Index (2016–2016)

Historical FCF Generation Index trend for Mersana Therapeutics Inc across 1 annual periods. Explore Mersana Therapeutics Inc (MRSN) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Mersana Therapeutics Inc (2016–2016)

Year-by-year Free Cash Flow Generation Index for Mersana Therapeutics Inc. For the full company profile including market capitalisation, see how much is Mersana Therapeutics Inc worth.

Year	FCG Index	Free Cash Flow (USD)	Operating CF	Capital Expenditures	YoY Change
2016	0.97x	$30.50 Million	$31.59 Million	$1.08 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).